ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AMRI Albany Molecular Research, Inc.

21.74
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Albany Molecular Research, Inc. NASDAQ:AMRI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 21.74 21.74 21.76 0 01:00:00

SHAREHOLDER ALERT: Schubert Firm Announces Investigation into Possible Breaches of Fiduciary Duty by Albany Molecular Researc...

28/07/2016 1:00pm

PR Newswire (US)


Albany Molecular Research, Inc. (NASDAQ:AMRI)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Albany Molecular Research, Inc. Charts.

SAN FRANCISCO, July 28, 2016 /PRNewswire/ -- Shareholder and consumer rights law firm Schubert Jonckheer & Kolbe LLP has launched an investigation into whether certain officers and directors of Albany Molecular Research Inc. (NASDAQ: AMRI) breached their fiduciary duties to the company and its shareholders by failing to implement adequate internal controls over the company's management and disclosure procedures.

On July 26, 2016, Judge Frederic Block denied a motion to dismiss a securities fraud class action filed against the company in the United States District Court for the Eastern District of New York. The class action alleges that between August 5, 2014 and November 5, 2014, Albany Molecular concealed from shareholders that a power outage at an acquired laboratory had contaminated the laboratory's inventory. Although the power outage occurred in July 2014, the truth was not revealed to investors until November 5, 2014 when the company announced that, due to the laboratory power failure, AMRI needed to discard moldy inventory and temporarily shut down the facility. On this news, company shares plummeted by $6.08 per share or 35%. On Tuesday, Judge Block denied the Company's motion to dismiss the class action, finding that Chief Executive Officer William Marth and then-acting Chief Financial Officer Michael Nolan must have known about the power outage because of the laboratory's importance to the company's core operations and the magnitude of the alleged false statements.

The Schubert Firm's investigation concerns whether the directors of Albany Molecular Research Inc. breached their fiduciary duties to the company and its shareholders by failing to maintain proper oversight and internal controls. Concerned shareholders who would like more information about their rights and potential remedies should contact Kathryn Schubert via email at kschubert@schubertlawfirm or by telephone at (415) 788-4220, or fill out the form on the firm's website at http://classactionlawyers.com/AMRI.

About Schubert Jonckheer & Kolbe

Schubert Jonckheer & Kolbe has extensive experience in prosecuting securities claims and has successfully represented investors throughout the nation in shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-schubert-firm-announces-investigation-into-possible-breaches-of-fiduciary-duty-by-albany-molecular-research-inc-officers-and-directors-300305351.html

SOURCE Schubert Jonckheer & Kolbe LLP

Copyright 2016 PR Newswire

1 Year Albany Molecular Research, Inc. Chart

1 Year Albany Molecular Research, Inc. Chart

1 Month Albany Molecular Research, Inc. Chart

1 Month Albany Molecular Research, Inc. Chart

Your Recent History

Delayed Upgrade Clock